Senior Manager, Advanced Analytics & Innovation
BeiGene
Summary
The Direct-to-Customer Innovation & Digital Health team is seeking a Senior Manager to help develop new ways to directly engage patients, caregivers, HCPs, and the broader oncology ecosystem.
Job description
The Senior Manager will primarily focus on digital and business analytics across hematologic malignancies and solid tumors, translating data into actionable insights to inform strategic and operational decisions. The role requires strong analytical skills, business judgment, and the ability to operate independently in a fast-moving, entrepreneurial environment. As opportunities arise, the individual may also contribute to R&D-focused AI initiatives and other innovation projects.
Digital & Business Analytics
- Lead a range of digital and business analyses to assess performance, identify opportunities, and inform strategic and operational decisions.
- Analyze diverse datasets, including healthcare claims, digital engagement data across channels, and other commercial and business data sources.
- Conduct performance measurement and impact analyses to evaluate the effectiveness of digital initiatives, marketing investments, and broader business activities.
- Partner with internal teams and external stakeholders to define business questions, integrate relevant data sources, and develop analytical approaches.
- Translate findings into actionable insights and recommendations to help teams prioritize investments, measure impact, and improve execution.
- Identify and implement opportunities to improve analytical capabilities, streamline processes, and drive efficiencies through AI and other technologies.
AI Innovation
- Support the identification and evaluation of emerging AI technologies and potential applications across R&D and other business functions.
- Collaborate with scientific and technical teams to explore potential use cases, assess feasibility, and support targeted evaluations or pilots.
- Contribute to broader innovation initiatives based on business priorities, team needs, and individual interests.
Qualifications
- Typically 5+ years of relevant experience in biopharma, healthcare technology, or consulting, with a strong emphasis on commercial or business analytics; equivalent combinations of advanced research and industry experience considered.
- Experience in hematology-oncology indications and associated market nuances.
- Hands-on experience analyzing healthcare and commercial data, assessing data quality, and translating findings into business recommendations.
- Proficiency with analytical and visualization tools such as SQL, Python, R, Power BI, or Tableau.
- Understanding of oncology R&D and commercial biopharma, with familiarity across hematologic malignancies and solid tumors.
- Working knowledge of AI and machine learning, including generative AI, and interest in exploring R&D applications; awareness of responsible AI, data privacy, intellectual property, and licensing considerations.
- Self-directed and entrepreneurial; comfortable defining problems, setting priorities, and advancing work in ambiguous, evolving environments.
- Strong relationship-building and influencing skills across commercial, R&D, technology, and external partners; able to communicate analytical findings and business implications to technical and nontechnical audiences.
Nice to Have
- Experience in innovation, start-ups, AI technology evaluation, search and evaluation, or scientific partnerships.
Requirements
- Typically 5+ years of relevant experience in biopharma, healthcare technology, or consulting, with a strong emphasis on commercial or business analytics
- Experience in hematology-oncology indications and associated market nuances
- Hands-on experience analyzing healthcare and commercial data, assessing data quality, and translating findings into business recommendations
- Proficiency with analytical and visualization tools such as SQL, Python, R, Power BI, or Tableau
- Understanding of oncology R&D and commercial biopharma, with familiarity across hematologic malignancies and solid tumors
- Working knowledge of AI and machine learning, including generative AI
- Awareness of responsible AI, data privacy, intellectual property, and licensing considerations
- Self-directed and entrepreneurial; comfortable defining problems, setting priorities, and advancing work in ambiguous, evolving environments
- Strong relationship-building and influencing skills across commercial, R&D, technology, and external partners
- Ability to communicate analytical findings and business implications to technical and nontechnical audiences
Benefits
- Medical, Dental & Vision
- 401(k)
- FSA/HSA
- Life Insurance
- Paid Time Off
- Wellness
- Annual Bonus Plan
- Incentive Compensation Plan
- Stock Ownership
- Employee Stock Purchase Plan
Company overview
BeiGene, Ltd., now rebranding as BeOne Medicines, is a global commercial-stage biotechnology company specializing in the discovery, development, manufacturing, and commercialization of innovative oncology medicines. Founded in 2010 by John V. Oyler and Xiaodong Wang, the company has grown into a multinational organization with headquarters in Cambridge, Massachusetts, Beijing, China, and Basel, Switzerland. BeiGene focuses on developing targeted and immune-oncology therapies for cancer treatment, with a diverse pipeline that includes internally discovered products like BRUKINSA (zanubrutinib), a Bruton's tyrosine kinase inhibitor, and Tevimbra (tislelizumab), a PD-1 inhibitor. The company operates across six continents with over 45 countries participating in clinical trials and has enrolled more than 30,000 patients in its research programs. With approximately 12,000 employees worldwide, BeiGene has established itself as a significant player in global oncology, particularly with strong market presence in China and expanding operations in the United States and Europe. The company's mission centers on expanding access to high-quality cancer therapies worldwide through persistent innovation and challenging traditional approaches to drug development.